These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 3013562)
21. [Susceptibility of Staphylococcus aureus isolated from blood to 11 antimicrobial agents and a review of the literature]. Viudes A; Pérez-Bellés C; Tallón P; Cano J; Peñalver MC; Pemán J; Gobernado G Rev Esp Quimioter; 2002 Jun; 15(2):158-68. PubMed ID: 12582445 [TBL] [Abstract][Full Text] [Related]
22. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. Singh R; Ray P; Das A; Sharma M J Antimicrob Chemother; 2010 Sep; 65(9):1955-8. PubMed ID: 20615927 [TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections. Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J J Antibiot (Tokyo); 2012 Oct; 65(10):505-8. PubMed ID: 22854340 [TBL] [Abstract][Full Text] [Related]
24. Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies. Vickers AA; O'Neill AJ; Chopra I J Antimicrob Chemother; 2007 Aug; 60(2):269-73. PubMed ID: 17556355 [TBL] [Abstract][Full Text] [Related]
25. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Hellmark B; Unemo M; Nilsdotter-Augustinsson A; Söderquist B Clin Microbiol Infect; 2009 Mar; 15(3):238-44. PubMed ID: 19196261 [TBL] [Abstract][Full Text] [Related]
26. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Simon VC; Simon M Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061 [TBL] [Abstract][Full Text] [Related]
27. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination. Perronne CM; Malinverni R; Glauser MP Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060 [TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus. Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice. Hirschl AM; Georgopoulos A; Stanek G; Breyer S; Rotter ML Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157 [TBL] [Abstract][Full Text] [Related]
30. Activity of coumermycin against clinical isolates of staphylococci. Guillemin MN; Miles HM; McDonald MI Antimicrob Agents Chemother; 1986 Apr; 29(4):608-10. PubMed ID: 3707109 [TBL] [Abstract][Full Text] [Related]
31. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus. Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632 [TBL] [Abstract][Full Text] [Related]
32. In vitro synergistic interaction of 5-O-methylglovanon and ampicillin against ampicillin resistant Staphylococcus aureus and Staphylococcus epidermidis isolates. Zhou X; Jia F; Liu X; Yang J; Zhang Y; Wang Y Arch Pharm Res; 2011 Oct; 34(10):1751-7. PubMed ID: 22076775 [TBL] [Abstract][Full Text] [Related]
33. [Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum]. Gevaudan MJ; Bollet C; Mallet MN; de Micco P Pathol Biol (Paris); 1991 May; 39(5):436-41. PubMed ID: 1652732 [TBL] [Abstract][Full Text] [Related]
34. Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents. Digranes A; Salveson A; Dibb WL Acta Pathol Microbiol Immunol Scand B; 1986 Apr; 94(2):85-8. PubMed ID: 3728027 [TBL] [Abstract][Full Text] [Related]
35. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs. Traub WH; Spohr M; Bauer D Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635 [TBL] [Abstract][Full Text] [Related]
36. Antibacterial activity of coumermycin alone and in combination with other antibiotics. Neu HC; Chin NX; Labthavikul P Antimicrob Agents Chemother; 1984 Jun; 25(6):687-9. PubMed ID: 6331295 [TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Deng LJ; Luh KT; Hsieh WC; Ho SW Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Mar; 14(1):1-9. PubMed ID: 7261697 [TBL] [Abstract][Full Text] [Related]
38. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis. Barr JG; Smyth ET; Hogg GM Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814 [TBL] [Abstract][Full Text] [Related]
39. Influence of various antibiotics on phagocytosis of Staphylococcus aureus by human polymorphonuclear leucocytes. Van der Auwera P; Husson M; Frühling J J Antimicrob Chemother; 1987 Sep; 20(3):399-404. PubMed ID: 3680077 [TBL] [Abstract][Full Text] [Related]
40. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium. Odenholt I; Löwdin E; Cars O Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]